Product Images Ropivacaine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Ropivacaine Hydrochloride NDC 55150-200 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 20 mL Container Label - ropivacaine fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 20 mL Container Label - ropivacaine fig1

This is a pharmaceutical product containing Ropivacaine hydrochloride USP in a 20mL single-dose vial for infiltration, nerve block use only, with a prescription. The vial is sterile and non-pyrogenic, and should be stored at room temperature between 20° and 25°C. The product is distributed by AuroMedics Pharma LLC and has a NDC number of 55150-195-20. It should be discarded if unused.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.75% (7.5 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig10

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.75% (7.5 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig10

This is a description of a drug called Ropivacaine Hydrochloride Injection, USP. The solution is available in a 150mg/20ml of 7.5mg/mL concentration for nerve block and epidural administration only, and is not for intravenous administration. It comes in a 25x20 mL single dose vial that is sterile and non-pyrogenic. The solution contains sodium chloride, and the pH is adjusted to 4.0-6.0 using hydrochloric acid and/or sodium hydroxide. It does not contain any preservatives and should be discarded if discolored or contains a precipitate. The drug is distributed by AumMedics Pharma LLC and made in India. The package insert has more information on recommended dosages and full prescribing details.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 10 mL Container Label - ropivacaine fig11

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 10 mL Container Label - ropivacaine fig11

This is a prescription drug with the trade name IRopivacaine Hydrochloride injection, used for epidural administration only. It is supplied in 10 mL single-dose vials, each containing 100 mg of the drug. The drug is sterile, nonpyrogenic, and pH adjusted using sodium hydroxide and/or hydrochloric acid. The usual dosage of the drug should be determined by consulting the package insert. This drug is manufactured in India by AuroMedics Pharma LLC.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 10 mL Container-Carton (25 Vials) - ropivacaine fig12

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 10 mL Container-Carton (25 Vials) - ropivacaine fig12

This is a description of a drug named Ropivacaine Hydrochloride Injection, USP. The drug is used for epidural administration only and must not be used for intravenous administration. It is stored at a temperature range of 20° to 25°C. The drug is available in 25x10 mL single-dose vials and is sterile and non-pyrogenic. Each mL of this drug contains Ropivacaine hydrochloride USP and sodium chloride 7.1 mg. The vial stoppers are not made with natural rubber latex.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 20 mL Container Label - ropivacaine fig13

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 20 mL Container Label - ropivacaine fig13

This is a description of a medication contained in a single-dose vial for epidural administration only, with the usual dosage available in the package insert. It contains Ropivacaine hydrochloride and Sodium chloride, with Sodium hydroxide and/or hydrochloric acid to adjust pH levels. The medication is sterile, non-pyrogenic, with a strength of 200 mg/20 mL. It is distributed by AuroMedics Pharma LLC and should be stored at 20°-25°C (68°-77°F).*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig14

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-1% (10 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig14

This is a description of a medication called Ropivacaine Hydrochloride Injection. The medication is sold in single dose vials, with each vial containing 200 mg of the medication (at a concentration of 10 mg/mL). The medication is intended for epidural use only, and should not be used intravenously. The medication does not contain any preservatives and should be discarded if unused. The dosage for this medication should be determined based on the recommendation provided in the package insert. The medication should not be used if the solution is discolored or contains a precipitate. The vial stoppers used are not made of natural rubber latex.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig2

This is a description of a medication called Ropivacaine Hydrochloride Injection. It is a single-dose container with 40mg of medication per 20mL vial. It is sterile and non-pyrogenic and is intended for infiltration, nerve block, and epidural administration only (not for intravenous administration). The medication contains ropivacaine hydrochloride USP, sodium chloride, and sodium hydroxide and/or hydrochloric acid to adjust the pH level. The solution does not contain preservatives and any unused portion must be discarded. The usual dosage and full prescribing information can be found in the package insert. The medication is distributed by AuroMedics Pharma LLC and is made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 100 mL Container Label - ropivacaine fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 100 mL Container Label - ropivacaine fig3

Auromedics Ropivacaine Hydrochloride Injection, USP is a prescription drug distributed by Sterie, Non-pyogenic e L S. It contains 200mg/100mL (2mg/mL) of Ropivacaine Hydrochloride and is for infiltration, nerve block, and epidural administration only. It is not advisable to use this injection for intravenous administration. Sodium chloride (8.6mg), sodium hydroxide, and hydrochloric acid are the contents contained in each mL. The solution does not contain any preservatives and is labeled for single-use only; unused portions should be discarded. The dosage instructions should be followed as prescribed in the package insert, and it’s advisable not to use the solution if it’s discolored or contains a precipitate. The solution should be stored at room temperature (20-25°C/68-77°F).*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 100 mL Container-Carton (1 Vial) - ropivacaine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2 mg/mL) - 100 mL Container-Carton (1 Vial) - ropivacaine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 20 mL Container Label - ropivacaine fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 20 mL Container Label - ropivacaine fig5

This is a description of a drug with the NDC code 55150-197-20. It is a nonpyrogenic sterile solution that contains Ropivacaine Hydrochloride USP and Ropivacaine Sodium Chloride. The solution also contains hydrochloride, sodium hydroxide, and/or hydrochloric acid to adjust the pH level. The dosage should be determined by consulting the package insert information. It is recommended to store the drug at 20°C to 25°C. The drug is distributed by AuroMedics Pharma LLC and the code is TS/DRUGS/1372010. The drug is suitable for infiltration, nerve block, and epidural admi, but not for intravenous adr. The size of the container is 20 mL and unused portions should be discarded.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 20 mL Container-Carton (25 Vials) - ropivacaine fig6

This appears to be a product description for a medication called Ropivacaine Hydrochloride Injection, USP, manufactured by AuroMedics. It is intended for infiltration, nerve block, and epidural administration only, and not for intravenous administration. The medication is available in single-dose vials and is sterile and non-pyrogenic. Each mL contains Ropivacaine hydrochloride USP, with a concentration of 5mg/mL, and sodium chloride at 8mg/mL. The solution may be autoclaved, and the usual dosage should be consulted in the package insert for full prescribing information. The stoppers are not made with natural rubber latex. The medication should be stored between 20° to 25°C (68° to 77°F) and should not be used if the solution is discolored or contains a precipitate.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 30 mL Container Label - ropivacaine fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 30 mL Container Label - ropivacaine fig7

This text is a product label for an injection medication containing Ropivacaine hydrochloride and Sodium chloride. It provides information on the dosage, storage instructions, and administration methods. It is distributed by AuroMedics Pharma LLC and is not intended for Intravenous Ads.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 30 mL Container-Carton (25 Vials) - ropivacaine fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.5% (5 mg/mL) - 30 mL Container-Carton (25 Vials) - ropivacaine fig8

This is a description of a sterile, non-pyrogenic solution of Ropivacaine Hydrochloride Injection, USP, containing 150 mg of Ropivacaine per 30 mL (5mg/mL). It is used for infiltration, nerve block, and epidural administration only, not for intravenous administration. The solution is packaged in 25 single-dose vials of 30 mL each, with stoppers that do not contain natural rubber latex. The solution should not be used if discolored or contains a precipitate. It does not contain any preservatives and should be discarded if unused. The dosage should be consulted on the package insert for full prescribing information. It is distributed by AuroMedics Pharma LLC, and made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.75% (7.5 mg/mL) - 20 mL Container Label - ropivacaine fig9

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.75% (7.5 mg/mL) - 20 mL Container Label - ropivacaine fig9

This is a medication containing 75mg of Ropivacaine hydrochloride USP in a 20mL single dose vial. It also contains sodium chloride and other ingredients to adjust the pH level. The medication is intended for nerve block and epidural administration only and should not be administered intravenously. Dosage instructions can be found on the package. It is distributed by AuroMedics Pharma LLC and should be stored at controlled room temperature. Unused portions should be discarded.*

Ropivacaine Hydrochloride Chemical Structure - ropivacaine str1

Ropivacaine Hydrochloride Chemical Structure - ropivacaine str1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.